Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × avelumab × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Breast 1

Conditions

Small Cell Lung Carcinoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Penile Neoplasms 1 PD-L1 Positive Mutation Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 Hemangiosarcoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Anus Neoplasms 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 Cyclophosphamide 8 apatinib 7 anlotinib 7 Vincristine 5 Dactinomycin 5 toripalimab 3 camrelizumab 3 Trabectedin 3 Etoposide 3 Docetaxel 3 brostallicin 2 Topotecan 2 Temozolomide 2 Sorafenib 2 Radiation Dose Hypofractionation 2 Oncolytic Virotherapy 2 Nivolumab 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Ipilimumab 2 Gene Expression Profiling 2 Gemcitabine 2 Drug Therapy 2 Busulfan 2 Amplified Fragment Length Polymorphism Analysis 2 trofosfamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02630368 2022-02-02

METROmaJX

Institut Bergonié

Phase 1/2 Unknown

Breast Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡